News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioMarin Pharmaceutical Inc. (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)


5/30/2012 9:12:05 AM

NOVATO, Calif., May 30, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that it has granted stock options, time-based restricted stock units and performance-based restricted stock units to Daniel Spiegelman, BioMarin's newly appointed Executive Vice President and Chief Financial Officer. These inducement awards were granted pursuant to the BioMarin Pharmaceutical Inc. 2012 Inducement Plan, approved by a majority of the independent directors of the Board on May 8, 2012 and granted as an inducement material to Mr. Spiegelman's employment with BioMarin in accordance with NASDAQ Listing Rule 5635(c)(4). BioMarin previously reported in its Current Report on Form 8-K filed May 9, 2012 with the Securities and Exchange Commission that Mr. Spiegelman was appointed Executive Vice President and Chief Financial Officer effective May 29, 2012.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES